The 2018 Western Australian Alcohol and Other Drug Excellence Awards: Recognising outstanding alcohol and other drug practice will be judged by an independent assessment process. The judges will assess all nominations against the specified evaluation criteria for each category and decide on up to three finalists and one winner for each category.

The recommended winners will be provided to the Assistant Mental Health Commissioner, Alcohol, Other Drugs and Prevention Services for final endorsement.

Finalists will be invited to attend the Awards ceremony at the 2018 Western Australian Alcohol and Other Drug Conference – Leading the Way: Embracing New Opportunities in the Alcohol and Other Drug Sector on 21 March 2018, at the Novotel Langley.

Finalists may attend the Awards ceremony free of charge, however attendance at the Conference outside of the Awards ceremony requires the purchase of a Conference registration. The winner in each category will remain confidential until the Awards ceremony. Throughout the judging process all information that has been supplied and submitted for entry will be kept strictly confidential and will only be disclosed to the judging panel.

It will not be possible to provide feedback on individual submissions. However, following the Awards ceremony general feedback can be requested.

Winners of each category will receive a certificate and prize. Finalists will receive a certificate.

Eligibility

The following conditions apply:

  • The group or organisation nominated must be based in Western Australia.
  • Only group or organisational applications will be considered.
  • Unless demonstrably different, previous award winners from 2012 or 2014 Alcohol and Other Drug Excellence Awards are not eligible to re-nominate the same initiative or project. However, finalists may re-nominate.
  • An initiative or project can be nominated in more than one category but can only win in one category.

Key Dates

Closing date for Award nominations: 1 December 2017
Nominees will be advised of the outcome of their submission by: 20 January 2018
Alcohol and Other Drug Excellence Awards Ceremony: 21 March 2018

Refusal of application

The Mental Health Commission and the Western Australian Network of Alcohol and other Drug Agencies reserve the right and the discretion to accept or reject nominations for the Awards. Their decision will be final and not subject to any further consultation or review.

Judging

Participation in the judging panel is voluntary and no payment will be provided for undertaking this role.
No outside correspondence will be considered and judges will be required to declare any possible conflict of interest. Any potential conflict of interest will be managed in accordance with the Mental Health Commission and Western Australian Network of Alcohol and other Drug Agencies Codes of Conduct.

Nomination form

  • A completed nomination form must accompany each submission.
  • The nomination form should include two referees.
  • A separate letter of endorsement must be signed by the organisation’s Chief Executive Officer, Board member or other authorised representative.

Evidence cited in application

Information and examples used in response to the category specific and general criteria must be verifiable. Evidence provided must be for recently completed (last 12 months) or current projects.

Written application

A written application, using Arial 12-point font must be submitted. It should include the following:

  • A project or program description of no more than 500 words
  • A statement addressing each of the selection criteria for the relevant Award category of no more than 1,000 words
  • Up to two A4 pages of supporting material

Award categories

The 2018 Alcohol and Other Drug (AOD) Excellence Award categories are:

  1. Prevention - Excellence in prevention
  2. Harm Reduction - Reducing the risk of AOD-related harms
  3. Treatment - Improved treatment outcomes for people with AOD issues
  4. Capacity Building - Building capacity to prevent and/or respond effectively to AOD issues
  5. Partnerships - Partnerships for improved AOD outcomes
  6. Aboriginal - Improving AOD outcomes for Aboriginal peoples
  7. Families - Excellence in working with families and carers
  8. Young People - Preventing and reducing AOD harms in young people
  9. Research into practice - Translating research into practice for improved AOD outcomes
  10. Consumer Participation - Significant/ongoing contribution to improving lives of people with AOD issues

Award category description and criteria

Prevention: Excellence in prevention
Brief description of category:
The development and implementation of effective prevention programs and projects is essential to prevent AOD-related harm across the population. This category recognises the achievements made by organisations who are leading the way in designing and implementing effective AOD prevention programs and projects.

The extent to which the project:

  1. Used prevention theory and practice to contribute to the prevention or minimisation of AOD-related harms for the target populations?
  2. Was based on best-practice evidence and/or how the project promoted innovation?
  3. Can be replicated?
  4. Involved relevant key stakeholders?
  5. Achieved any other AOD outcomes?

Harm Reduction – Reducing the risk of AOD-related harms
Brief description of category:
Harm reduction includes policies, programs and practices that aim primarily to reduce the adverse health, social and economic consequences of AOD use for individuals and communities. This category recognises the achievements of organisations that have implemented evidence-based harm reduction strategies to reduce AOD-related harms for individuals or communities.

The extent to which the project:

  1. Used harm reduction principles to contribute to the prevention or minimisation of AOD-related harm for the target population/s?
  2. Was based on evidence-based best practice and/or how the project promoted innovation?
  3. Can be replicated?
  4. Involved relevant key stakeholders?
  5. Achieved any other AOD outcomes?

Treatment - Improved treatment outcomes for people with AOD issues
Brief description of category:
Treatment services have a key role in responding to AOD-related harm. Effective treatment can significantly improve the health and quality of life for people with AOD issues and their families. This category recognises the outstanding achievement of an organisation providing treatment services.

The extent to which the project:

  1. Improved treatment outcomes for people in AOD treatment?
  2. Was based on best-practice evidence and/or how the project promoted innovation?
  3. Can be replicated?
  4. Involved consumers?
  5. Achieved any other AOD outcomes?

Capacity Building - Building capacity to prevent and/or respond effectively to AOD issues
Brief description of category:
Building the capacity of the workforce, groups or community to prevent, respond to and reduce the harm from AOD use requires a range of strategies that focus on individuals, organisations and systems. This category recognises the achievements made by organisations, groups or communities in designing and delivering programs targeting the workforce, groups or communities to improve their capacity to respond to AOD issues.

The extent to which the project:

  1. Built or increased the capacity of the workforce, groups or communities to prevent and/or respond to AOD-related harm?
  2. Was based on best-practice evidence and/or how the project promoted innovation?
  3. Can be replicated?
  4. Gains can be sustained over time?
  5. Achieved any other AOD outcomes?

Partnerships – Partnerships for improved AOD outcomes
Brief description of category:
The achievement of improved AOD outcomes requires genuine partnerships with key stakeholders such as consumers, families, communities, government, non-government organisations and across sectors and services. This category recognises programs and organisations that develop and sustain effective partnerships with key stakeholders in order to achieve AOD outcomes.

The extent to which the project:

  1. Improved the quality of AOD outcomes for individuals, families and/or communities?
  2. Demonstrated effective consultation, collaboration and partnerships with relevant stakeholders?
  3. Can be replicated?
  4. Gains can be sustained over time?
  5. Achieved any other AOD outcomes?

Aboriginal - Improving AOD outcomes for Aboriginal peoples
Brief description of category:
The prevention and minimisation of AOD issues in Aboriginal communities requires culturally appropriate responses. This category celebrates the achievements of groups or organisations that have implemented effective AOD programs and achieved outstanding outcomes for Aboriginal peoples and Aboriginal communities.

The extent to which the project:

  1. Contributed to the prevention or minimisation of AOD-related harm for Aboriginal peoples?
  2. Was based on best-practice evidence and/or how the project promoted innovation?
  3. Can be replicated?
  4. Involved relevant key stakeholders?
  5. Achieved any other AOD outcomes?
  6. Demonstrated Aboriginal ways of working and addressed the issue of access for Aboriginal peoples?

Families - Excellence in working with families and carers
Brief description of category:
Including families and carers of AOD users in treatment and prevention programs, increases the likelihood of improved AOD outcomes for clients, families/carers and the community. This category recognises the achievements of organisations that have developed programs involving families and carers to improve AOD outcomes for people with AOD-related issues.

The extent to which the project:

  1. Improved outcomes for carers/family members?
  2. Included carers and family members?
  3. Was based on best-practice evidence and/or how the project promoted innovation?
  4. Can be replicated?
  5. Achieved any other AOD outcomes?

Young people - Preventing and reducing AOD harms in young people
Brief description of category:
Implementing effective prevention, early intervention and treatment programs and services in childhood and adolescence can result in the prevention and reduction of harms associated with AOD use. This category recognises the achievements made by organisations and groups working to prevent and reduce AOD related harm amongst young people.

The extent to which the project:

  1. Contributed to the prevention or minimisation of AOD-related harms for young people?
  2. Was based on best-practice evidence and/or how the project promoted innovation?
  3. Can be replicated?
  4. Gains can be sustained over time?
  5. Achieved any other AOD outcomes?

Research into practice – Translating research into practice for improved AOD outcomes
Brief description of category:
Research does not automatically result in improved outcomes. This category recognises programs or projects which demonstrate the practical application of evidence-based research in their design, implementation or evaluation, which contributes to improved outcomes for people experiencing AOD-related harms.

The extent to which the project:

  1. Incorporated evidence-based research in the design, implementation or evaluation?
  2. Promoted innovation?
  3. Improved outcomes for people experiencing AOD-related harms?
  4. Embedded research-based evidence into practice?
  5. Can be replicated?

Consumer participation - Significant/ongoing contribution to improving lives of people with AOD issues
Brief description of category:
This category recognises programs or projects which have significantly increased AOD consumer participation resulting in improved outcomes for people experiencing AOD-related harms or individual AOD consumers who have made a significant and ongoing contribution to improving the lives of people with AOD issues.

The extent to which the consumer or program/ project:

  1. Championed consumer engagement into the AOD sector?
  2. Improved the quality of life and well-being of people with AOD related issues?
  3. Utilised principles of consumer engagement which reflect best-practice, for example, participation, diversity, accountability (See http://www.hconc.org.au/resources/engagement-in-the-alcohol-and-other-drugs-sector/).
  4. Can be replicated?
  5. Gains can be sustained over time?

Contact details: For enquiries regarding the Alcohol and Other Drug Excellence Awards,
please contact This email address is being protected from spambots. You need JavaScript enabled to view it. or phone (08) 6553 0560